Inhibition of multiplication of herpes simplex virus by caffeic acid. 2011

Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
Division of Virology, Department of Cellular and Molecular Medicine, Graduate School of Medicine, Wakayama Medical University, Wakayama 641-0011, Japan.

Hot water extracts of coffee grinds and commercial instant coffee solutions have been shown to exhibit marked antiviral and virucidal activities against herpes simplex virus type 1 (HSV-1). Specifically, it has been shown that caffeine and N-methyl-pyridinium formate inhibit the multiplication of HSV-1 in HEp-2 cells. The present study examined the virological properties and the antiviral activity of caffeic acid against HSV-1. Caffeic acid inhibited the multiplication of HSV-1 in vitro, while chlorogenic acid, a caffeic acid ester with quinic acid, did not. These reagents did not have a direct virucidal effect. The one-step growth curve of HSV-1 showed that the addition of caffeic acid at 8 h post infection (h p.i.) did not significantly affect the formation of progeny viruses. An analysis of the influence of the time of caffeic acid addition, revealed that addition at an early time post infection remarkably inhibited the formation of progeny infectious virus in the infected cells, but its addition after 6 h p.i. (i.e., the time of the completion of viral genome replication) did not efficiently inhibit this process. These results indicate that caffeic acid inhibits HSV-1 multiplication mainly before the completion of viral DNA replication, but not thereafter. Although caffeic acid showed some cytotoxicity by prolonged incubation, the observed antiviral activity is likely not the secondary result of the cytotoxic effect of the reagent, because the inhibition of the virus multiplication was observed before appearance of the notable cytotoxicity.

UI MeSH Term Description Entries
D002109 Caffeic Acids A class of phenolic acids related to chlorogenic acid, p-coumaric acid, vanillic acid, etc., which are found in plant tissues. It is involved in plant growth regulation. Acids, Caffeic
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D018139 Simplexvirus A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN. Herpes Simplex Virus,Herpesvirus 1, Saimiriine,Herpesvirus 1, Saimirine,Herpesvirus 16, Cercopithecine,Marmoset Virus,Cercopithecine Herpesvirus 16,Herpes Labialis Virus,Herpes-T Virus,Herpesvirus 1 (alpha), Saimirine,Herpesvirus Hominis,Herpesvirus Papio 2,Herpesvirus Platyrhinae,Marmoset Herpesvirus,Saimiriine Herpesvirus 1,Herpes Labialis Viruses,Herpes Simplex Viruses,Herpes T Virus,Herpes-T Viruses,Herpesvirus Homini,Herpesvirus, Marmoset,Herpesviruses, Marmoset,Homini, Herpesvirus,Hominis, Herpesvirus,Labialis Virus, Herpes,Labialis Viruses, Herpes,Marmoset Herpesviruses,Marmoset Viruses,Platyrhinae, Herpesvirus,Saimirine Herpesvirus 1,Simplexviruses,Virus, Herpes Labialis,Viruses, Herpes Labialis

Related Publications

Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
May 1965, Biochimica et biophysica acta,
Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
January 1978, IARC scientific publications,
Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
June 1980, Antimicrobial agents and chemotherapy,
Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
January 1975, Intervirology,
Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
October 2014, International journal of molecular medicine,
Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
July 1982, Infection and immunity,
Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
September 1974, Antimicrobial agents and chemotherapy,
Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
January 1997, Antiviral research,
Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
October 1984, Virology,
Keiko Ikeda, and Kazuko Tsujimoto, and Misao Uozaki, and Mitsunori Nishide, and Yukiko Suzuki, and A Hajime Koyama, and Hisashi Yamasaki
January 1965, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!